BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38358158)

  • 1. Pancreatic Resection for Pancreatic Tumors our Experience at Suburban Hospital.
    Nichkaode PB; Sharma B; Reddy S; Inturi RT
    Ann Afr Med; 2023; 22(4):537-543. PubMed ID: 38358158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery for mucin-producing pancreatic tumor.
    Yasuda H; Takada T; Amano H; Yoshida M
    Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical experience with pancreatic and periampullary cancer.
    Herter FP; Cooperman AM; Ahlborn TN; Antinori C
    Ann Surg; 1982 Mar; 195(3):274-81. PubMed ID: 6277259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?
    Sasson AR; Hoffman JP; Ross EA; Kagan SA; Pingpank JF; Eisenberg BL
    J Gastrointest Surg; 2002; 6(2):147-57; discussion 157-8. PubMed ID: 11992799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects].
    Ryska M; Strnad R; Belina F; Zavoral M; Sálek C; Hrabal P; Buric I; Lásziková E; Kvicerová H; Jurenka B; Holcátová I
    Rozhl Chir; 2007 Aug; 86(8):432-9. PubMed ID: 17969981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.
    Christein JD; Kendrick ML; Iqbal CW; Nagorney DM; Farnell MB
    J Gastrointest Surg; 2005; 9(7):922-7. PubMed ID: 16137585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas.
    Hoffman JP; Weese JL; Solin LJ; Engstrom P; Agarwal P; Barber LW; Guttmann MC; Litwin S; Salazar H; Eisenberg BL
    Am J Surg; 1995 Jan; 169(1):71-7; discussion 77-8. PubMed ID: 7818001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the effect of age on pancreatic resection?
    Riall TS
    Adv Surg; 2009; 43():233-49. PubMed ID: 19845182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC; Klimstra DS; Brennan MF
    Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
    Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions.
    Müller MW; Friess H; Kleeff J; Hinz U; Wente MN; Paramythiotis D; Berberat PO; Ceyhan GO; Büchler MW
    Ann Surg; 2006 Dec; 244(6):909-18; discussion 918-20. PubMed ID: 17122616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resections.
    Gangl O; Sahora K; Kornprat P; Margreiter C; Primavesi F; Bareck E; Schindl M; Längle F; Öfner D; Mischinger HJ; Pratschke J; Gnant M; Függer R
    World J Surg; 2014 Feb; 38(2):456-62. PubMed ID: 24121365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.